Efficacy of atypical antipsychotic agents for maintenance therapy of schizophrenia
Omori, T.
Seishin Shinkeigaku Zasshi 103(6): 470-475
2001
ISSN/ISBN: 0033-2658 PMID: 11573295 Document Number: 534573
Document emailed within 1 workday
Related Documents
Vohora, D. 2007: Atypical antipsychotic drugs: current issues of safety and efficacy in the management of schizophrenia Current Opinion in Investigational Drugs 8(7): 531-538Shoshina, I.I.; Shelepin, I.E.; Semenova, N.B. 2014: The frequency-contrast sensitivity of visual stimulus perception in patients with schizophrenia with the therapy of atypical and typical antipsychotic drugs Fiziologiia Cheloveka 40(1): 43-48
Gosselin, O.; Di Scala, G.; Ribeyre, J.M.; Kahn, J.P. 1996: New antipsychotic agents: new paths of research on the notion of atypical agents L'Encephale 22(Special Issue 6): 3-6
Weiden, P.; Aquila, R.; Standard, J. 1996: Atypical antipsychotic drugs and long-term outcome in schizophrenia Journal of Clinical Psychiatry 57(Suppl): 53-60
Jones, B.; Basson, B.R.; Walker, D.J.; Crawford, A.M.; Kinon, B.J. 2001: Weight change and atypical antipsychotic treatment in patients with schizophrenia Journal of Clinical Psychiatry 62(Suppl): 41-44
Roth, B.L.; Ciaranello, R.D.; Meltzer, H.Y. 1992: Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors Journal of Pharmacology and Experimental Therapeutics 260(3): 1361-1365
Gram, L.F. 2000: Malignant neuroleptic syndrome in treatment with the new, atypical antipsychotic agents, risperidone and olanzapine Ugeskrift for Laeger 162(13): 1914-1915
Franza, F. 2016: Risk and efficacy in cognitive functions in Bipolar Disorder Ii with atypical antipsychotic augmentation Psychiatria Danubina 28(Suppl-1): 13-17
Srisurapanont, M.; Maneeton, N. 1999: Comparison of the efficacy and acceptability of atypical antipsychotic drugs: a meta-analysis of randomized, placebo-controlled trials Journal of the Medical Association of Thailand 82(4): 341-346
Roth, B.L.; Craigo, S.C.; Choudhary, M.S.; Uluer, A.; Monsma, F.J.; Shen, Y.; Meltzer, H.Y.; Sibley, D.R. 1994: Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors Journal of Pharmacology and Experimental Therapeutics 268(3): 1403-1410
Naber, D. 2000: Long-term phase of schizophrenia: impact of atypical agents International Clinical Psychopharmacology 15(Suppl 4): S11-S14
Klushnik, T.P.; Syriachenko, T.M.; Brusov, O.S.; Sarmanova, Z.V.; Otman, I.N.; Dupin, A.M.; Sokolov, R.E. 2008: Serum immunological markers as predictors of effectiveness of antipsychotic therapy in patients with schizophrenia Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 108(1): 31-35
Diurni, M.; Baranzini, F.; Costantini, C.; Poloni, N.; Vender, S.; Callegari, C. 2009: Metabolic side effects of second generation antipsychotic agents in antipsychotic-naïve patients: preliminary study Recenti Progressi in Medicina 100(2): 103
Balla, P.; Frecska, E. 2012: Maintenance therapy in schizophrenia -- a brief review of the literature Neuropsychopharmacologia Hungarica: a Magyar Pszichofarmakologiai Egyesulet Lapja 14(3): 197-200
Lecrubier, Y. 2000: Is amisulpride an 'atypical' atypical antipsychotic agent? International Clinical Psychopharmacology 15(Suppl 4): S21-S26
Skopová, J.; Faltus, F.; Filip, V.; Jirák, R.; Karen, P.; Posmurová, M.; Dobiásová, A. 1985: Fluspirilene in schizophrenia maintenance therapy and its interaction with dexetimide Ceskoslovenska Psychiatrie 81(6): 414-419
Johnson, D.A. 1984: Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia Journal of Clinical Psychiatry 45(5 Part 2): 13-21
Wilson, L.G.; Roberts, R.W.; Gerber, C.J.; Johnson, M.H. 1982: Pimozide versus chlorpromazine in chronic schizophrenia: a 52 week double-blind study of maintenance therapy Journal of Clinical Psychiatry 43(2): 62-65
Nightengale, B.S.; Crumly, J.M.; Liao, J.; Lawrence, B.J.; Jacobs, E.W. 1998: Economic outcomes of antipsychotic agents in a Medicaid population: traditional agents vs. risperidone Psychopharmacology Bulletin 34(3): 373-382
Hirsch, S.R.; Link, C.G.; Goldstein, J.M.; Arvanitis, L.A. 1996: ICi 204,636: a new atypical antipsychotic drug British Journal of Psychiatry. Suppl 29: 45-56